Related Experiment Video
Updated: May 3, 2026

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
Published on: May 4, 2018
PrtR homeostasis contributes to Pseudomonas aeruginosa pathogenesis and resistance against ciprofloxacin
Ziyu Sun1, Jing Shi, Chang Liu
1Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai University, Tianjin, China.
Abstract:
Pseudomonas aeruginosa is an opportunistic pathogen that causes acute and chronic infections in humans. Pyocins are bacteriocins produced by P. aeruginosa that are usually released through lysis of the producer strains. Expression of pyocin genes is negatively regulated by PrtR, which gets cleaved under SOS response, leading to upregulation of pyocin synthetic genes. Previously, we demonstrated that PrtR is required for the expression of type III secretion system (T3SS), which is an important virulence component of P. aeruginosa. In this study, we demonstrate that mutation in prtR results in reduced bacterial colonization in a mouse acute pneumonia model. Examination of bacterial and host cells in the bronchoalveolar lavage fluids from infected mice revealed that expression of PrtR is induced by reactive oxygen species (ROS) released by neutrophils. We further demonstrate that treatment with hydrogen peroxide or ciprofloxacin, known to induce the SOS response and pyocin production, resulted in an elevated PrtR mRNA level. Overexpression of PrtR by a tac promoter repressed the endogenous prtR promoter activity, and electrophoretic mobility shift assay revealed that PrtR binds to its own promoter, suggesting an autorepressive mechanism of regulation. A high level of PrtR expressed from a plasmid resulted in increased T3SS gene expression during infection and higher resistance against ciprofloxacin. Overall, our results suggest that the autorepression of PrtR contributes to the maintenance of a relatively stable level of PrtR, which is permissive to T3SS gene expression in the presence of ROS while increasing bacterial tolerance to stresses, such as ciprofloxacin, by limiting pyocin production.
Insights
The regulatory protein PrtR in Pseudomonas aeruginosa is induced by reactive oxygen species and autorepresses its own expression. This autoregulation maintains PrtR levels, enabling type III secretion system gene expression and enhancing bacterial stress resistance.
Area of Science:
- Microbiology
- Bacterial Pathogenesis
- Molecular Biology
Background:
- Pseudomonas aeruginosa is an opportunistic pathogen causing human infections.
- Pyocins are bacteriocins produced by P. aeruginosa, regulated by PrtR.
- PrtR is crucial for type III secretion system (T3SS) virulence factor expression.
Purpose of the Study:
- Investigate the role of PrtR in P. aeruginosa virulence.
- Determine the regulation and function of PrtR during infection.
- Elucidate the autoregulatory mechanism of PrtR.
Main Methods:
- Mouse acute pneumonia model for colonization studies.
- Analysis of PrtR expression induced by reactive oxygen species (ROS) and SOS response.
- Electrophoretic mobility shift assay (EMSA) to study PrtR promoter binding.
- Gene expression analysis of T3SS and pyocin genes.
Main Results:
- prtR mutation reduced bacterial colonization in a mouse model.
- PrtR expression is induced by ROS and SOS-inducing agents (H2O2, ciprofloxacin).
- PrtR binds to its own promoter, indicating autorepression.
- High PrtR levels increased T3SS expression and ciprofloxacin resistance.
Conclusions:
- PrtR autorepression maintains stable levels, supporting T3SS expression under ROS.
- This autoregulation enhances bacterial tolerance to stresses like ciprofloxacin by modulating pyocin production.
More Related Videos
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
Microbiota of the Respiratory Tract
Clinical Significance of Antibiotic Resistance
Urinary Tract Infection II: Pathophysiology

